BioSpace News Archive

Wilmington, Delaware, United States: According to the report, the global addiction treatment market was valued at ~US$ 6 Bn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2030.

The global structural biology and molecular modeling techniques market is a novel conception in the global healthcare sector and has already made key contributions in obtaining remedies to a number of diseases.

Wilmington, Delaware, United States: Surge in the prevalence of different infectious diseases globally is projected to create substantial opportunities for sales growth in the isothermal nucleic acid amplification technology market during the forecast period of 2021 to 2031.

Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company on a mission to deliver transformative therapies for rare cancers, today announced the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for momelotinib.

The AmerisourceBergen Foundation , an independent not-for-profit charitable giving organization focused on supporting health-related causes that enrich the global community, has committed $150,000 to the United Nations Foundation ’s Shot@Life campaign to support vaccine equity.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Nasdaq has halted trading of the company’s common stock.

The latest market analysis report published by Reports and Data, titled ‘Global Alzheimer’s Pipeline Drug Market – Forecast to 2027,’ thoroughly examines the Alzheimer’s Pipeline Drug industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Dengue Testing Market – Forecast to 2028,’ thoroughly examines the Dengue Testing industry to provide essential data & information for the targeted readers. The report consists of quantitative and qualitative research on the market performed by our market experts.

The global generic injectables market size was significantly robust in 2020 and is expected to register a steady revenue CAGR over the forecast period.

The global insulin delivery devices market to reach USD 33.19 Billion by 2028 at a CAGR of 9.31%, according to the latest report by Reports and Data.